ECM
GDRX icon

Endurant Capital Management’s GoodRx Holdings GDRX Stock Holding History

Endurant Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-87,290
Closed -$491K – 39
2023
Q3 		$491K Buy
+87,290
New +$582K 0.44% 39
2022
Q1 		– Sell
-68,599
Closed -$2.24M – 72
2021
Q4 		$2.24M Buy
+68,599
New +$2.76M 0.54% 38
2021
Q2 		– Sell
-136,480
Closed -$5.33M – 71
2021
Q1 		$5.33M Buy
136,480
+59,101
+76% +$2.66M 1.39% 28
2020
Q4 		$3.12M Buy
+77,379
New +$3.55M 1.13% 30

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Endurant Capital Management's GDRX Position: Q4 2023 in Review

Endurant Capital Management sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 87,290 shares — an estimated $491K sold.

Endurant Capital Management first reported a position in GDRX in Q4 2020 and held it in 4 quarters. The position peaked at $5.33M in Q1 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • Endurant Capital Management reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • Endurant Capital Management sold 87,290 GoodRx Holdings shares in Q4 2023, an estimated $491K.
  • Endurant Capital Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 4 quarters.
  • Endurant Capital Management's GoodRx Holdings position peaked at $5.33M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.